Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Brentuximab-Induced Acute Interstitial Nephritis: A Case Report

Matthew Patterson, Pouneh Dokouhaki, Chance S. Dumaine [...]

Canadian Journal of Kidney Health and Disease

Retricted access

Case report

First published 2021-3

Rapid desensitization to brentuximab vedotin after severe anaphylaxis in the treatment of refractory Hodgkin’s lymphoma

Rosalaura V. Villarreal-Gonzalez, Sandra N. Gonzalez-Diaz, Cindy E. de Lira-Quezada [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2012

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkins Lymphoma: Focus on Brentuximab Vedotin

Michelle Furtado, Simon Rule

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2012-3

Brentuximab Vedotin: A New Age in the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Stephanie S Minich

Annals of Pharmacotherapy

Retricted access

Case report

First published 2022-7

Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma

Rosalaura V Villarreal-González, Sandra N González-Díaz, Wendy J Santos-Fernández [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023

New-onset persistent hyperglycemia with initiation of brentuximab treatment

Joseph Quintas, Kelley B Mowatt, Jamie A Mullally [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2018-9

Update on the role of brentuximab vedotin in classical Hodgkin lymphoma

Sarah Tomassetti, Alex F. Herrera

Therapeutic Advances in Hematology

Free access

Research article

First published 2012-8

Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma

Christos Vaklavas, Andres Forero-Torres

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2023-4

Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series

Alessandro Broccoli, Lisa Argnani, Paolo Elia Coppola [...]

Tumori Journal

Retricted access

Research article

First published 2013-9

Severe infusion reactions to brentuximab vedotin in two patients with Hodgkin lymphoma previously treated with allogeneic stem cell transplantation

Allison A Baxley, Debra E Kumm, Courtney B Bishop [...]

Journal of Oncology Pharmacy Practice

Search results